Skip to main content
. Author manuscript; available in PMC: 2020 Aug 7.
Published in final edited form as: J Geriatr Oncol. 2020 Jan 10;11(3):369–379. doi: 10.1016/j.jgo.2019.12.007
doi only
Reviewer name
Article title
Date of publication
Journal British Journal of Cancer
Cancer
European Journal of Cancer
Lancet
Lancet Oncology
Annals of Oncology
NEJM
Journal of Clinical Oncology
CA: A Cancer Journal for
Clinicians
Journal of the NCI
Cancer Research
International Journal of Cancer
Neuro-Oncology
Cancer Treatment Reviews
Journal of the National
Comprehensive Cancer
Network
Advances in Cancer Research
Other
Other journal title
Cancer site (select all that apply) Breast
Prostate
Lung
Colorectal
Gynecologic
Bladder
Kidney
Leukemia
Lymphoma
Melanoma
Pancreas
Thyroid
Head & Neck
Brain
Four or more
Other GI
Other
Please specify the other type of GI cancer
Please specify other type of cancer
Methods Section (Full Text)
Are any “inclusion/exclusion criteria” included in the methods section? Yes
No
Do the inclusion/exclusion criteria include an “upper age cut-off point”? Yes
No
Results Section (Full Text)
How is “age” presented in the demographics Age categories
Age range
Mean/Standard Deviation
Median/Standard Deviation
Mean/Range
Median/Range
Other
Please specify
Is there a component of the Results Section that “stratified by age”? (presents data for different age groups such as 45 to 64 and 65 and older) Yes
No
What are the “age stratification categories”? Yes
No
Is effectiveness of “cancer treatment” presented in the Results Section? Yes
No
Is there an age stratification subset analysis of the effectiveness of the cancer treatment? Yes
No
Are “adverse events/complications” presented in the Results Section? Yes
No
Is there an age stratification analysis for adverse events/complications? Yes
No
Discussion (Full Text)
Is the effective of cancer treatment based on age discussed? Yes
No
Is the lack of effectiveness of cancer treatment results based on age listed as a study limitation? Yes
No
Are age stratification “adverse events/complications” discussed”? Yes
No
Is the lack of data on adverse events/complications based on age listed as a study limitation? Yes
Is there lack of other age-related issues/items mentioned as a study limitation? Yes
No